Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you have safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Contact Us

Grantee Research Project Results

2005 Progress Report: Pulmonary Biomarkers Based on Alterations in Protein Expression Following Exposure to Arsenic

EPA Grant Number: R832095
Title: Pulmonary Biomarkers Based on Alterations in Protein Expression Following Exposure to Arsenic
Investigators: Lantz, R. Clark , Boitano, Scott A. , Burgess, Jefferey L.
Institution: University of Arizona
EPA Project Officer: Aja, Hayley
Project Period: January 8, 2005 through January 16, 2009
Project Period Covered by this Report: January 8, 2005 through January 7,2009
Project Amount: $731,453
RFA: Application of Biomarkers to Environmental Health and Risk Assessment (2004) RFA Text |  Recipients Lists
Research Category: Hazardous Waste/Remediation

Objective:

Exposure to arsenic (As) has been linked to lung cancer. Environmental exposure to these metals will result in multiple adverse effects, which can be characterized through evaluation of alterations in protein expression. We will evaluate such alterations as biomarkers of exposure and effect prior to the development of cancer. This study will use the technology of proteomics to evaluate and identify biomarkers of chronic environmental exposure to As by evaluating large numbers of proteins simultaneously. We will compare alterations in protein expression in exposed human populations in Arizona, human cell lines, and in vivo rodent studies. Patterns of alterations in protein expression, both common and unique to these different cell types, will be identified. These will be correlated with alterations in DNA oxidation in induced sputum from the lung, which we have recently found to be related to the levels of arsenic exposure.

Progress Summary:

In vitro responses to arsenic
To explore arsenic-induced alterations, we exposed confluent bronchial airway epithelial cell cultures (16HBE) to 30, 60 or 290 ppb arsenite and monitored wound healing, activity of metalloproteinases and associated intracellular Ca2+ concentration ([Ca2+]i) changes. Following a 24 exposure to arsenic, the ability of the cells to undergo mechanical wound repair was inhibited by arsenic exposures of 60 ppb and greater. This was accompanied by an increase in the levels and activity of MMP-9.  Mechanical wounding results in a coordinated increase in [Ca2+]i among neighboring cells (calcium wave).  Arsenic at 60 ppb resulted in a slight decrease in the number of cells involved in the calcium wave.  However, the difference was not significant.  Because wound-induced calcium signaling is blocked by apyrase, we also tested whether arsenite treated cells displayed altered responses to purinergic agonists.  Treatment with 60 ppb arsenite for 24 hours resulted in a significant reduction in the number of cells responding to ATP stimulation.  Over 50% of untreated cells responded with increased [Ca2+]i after stimulation with 1 mM ATP.  60 ppb arsenite treatment reduced the percentage of responding cells to 20%.  While over 30% of cells responded to 500 nM ATP stimulation, this was reduced to 4% in arsenic treated cells.  Taken together, these data indicate that environmental levels of arsenic can reduce purinergic dependent [Ca2+]i signaling and wound healing in human bronchial epithelial cells. 
 
We have previously shown that arsenic delays the ability of cells to form monolayers.  To test if arsenic altered functional tight junctions, we repeated the experiments from above, with cells grown on nuclepore filter supports and directly measured transepithelial resistance (TER) in the presence or absence of arsenic. Arsenic added at the time of plating greatly reduced the ability of the cells to form a functional monolayer.  This was apparent even at 60 ppb.  If cells were first allowed to form a tight monolayer prior to addition of arsenic, high levels of arsenic were still capable of reducing the epithelial resistance.  Cells exposed under these conditions showed alterations in the levels and types of expression of tight junctional proteins, occuldin and claudins.
 
In vivo animal responses to arsenic exposure
We have analyzed altered protein expression in the lung lining fluid and airway epithelial cells of mice exposed to arsenic in their drinking water for up to 4 weeks.  Soluble proteins in the lung lining fluid were obtained through bronchoalveolar lavage (BAL).  Proteins were identified using 2-D gel electrophoresis (N=3) or multidimensional protein identification technology (MUDPIT) (N=2) coupled with mass spectrometry (MS). A total of 44 proteins were identified.  Proteins that were seen to be present in the BAL of control animals while absent in the treated animals include:  glutathione-S-transferase omega-1 (GST-omega-1), contraspin, apolipoprotein A-I and A-IV, receptor for advanced glycation end products (RAGE) and alpha-1-antitrypsin (AAT). Proteins up regulated by arsenic included enolase-1 and peroxiredoxin-6  Using Western Blot analysis, we have shown that levels of RAGE in the BAL decreases as a function of arsenic treatment in mice treated with arsenic in their drinking water.   Previous investigators have identified GST omega-1 as an important arsenic metabolizing enzyme.  The function of RAGE in chronic inflammatory disease, wound healing and cancer has been previously reported.  In addition, alpha-1-antitrypsin levels were also affected by arsenic treatment. We have also used a selective airway epithelial cell digestion to isolate and analyze altered proteins.  Using MUDPIT analysis we have identified over 150 proteins changed by arsenic.  We have also analyzed the most likely cell functions and disease states that are associated with the altered proteins from BAL and from the cell fractions.  Using a curated analysis system (MetaCore) we have identified cell motility and alteration in wound repair as the most likely affected cellular functions and disease.  This is consistent with our in vitro data.   In order to verify wound healing as a site of action of arsenic, we have examined the effect of arsenic on the time for recovery from epithelial damage caused by exposure to naphthalene.  We have found that while normal recoevery from naphthalene exposure occurs within 2 weeks of exposure, damage in animals that had been exposed to arsenic was still present after 2 weeks.  These data indicate that asenic can affect wound healing in an animal model. 
 
Human population studies
Because of the importance of MMPs, RAGE and alpha-1antrypsin in chronic inflammatory diseases we investigated arsenic-induced alterations in these proteins in human induced-sputum.  Samples were collected from 56 individuals living in Ajo, Arizona (tap water arsenic ~ 20 ppb) and from Tucson, Arizona (tap water arsenic ~ 5 ppb).  First morning void urine was also collected and arsenic speciation analysis was performed.  MMP-2, MMP-9, TIMP-1, RAGE and AAT levels in sputum were determined using commercially available ELISA kits.  Regression analysis demonstrated a significant positive correlation between sputum MMP-9/TIMP-1 ratios (p=0.005) and total urinary inorganic arsenic.  Sputum levels of RAGE (p=0.016) and AAT (p-0.028) were also significantly negatively correlated with levels of total urinary arsenic.  This is a similar response to that seen in our in vitro and animal models.  Therefore, use of in vitro and animal models combined with proteomics approaches provide an unbiased determination of important biomarkers that may be related to human disease. Most recently, in a separate, higher exposed population (65 ppb) we have found that serum MMP-9 appears to be positively correlated with arsenic exposures. 
 
Conclusions:
Our strategy of use in vitro and in vivo model systems to predict arsenic-induced alterations in humans has been very successful.  We have tested three potential makers discovered in our model systems and all have been altered in a similar fashion is humans populations exposed to arsenic in their drinking water.  In addition, we have identified some unique effects of environmental levels of arsenic exposure that had not previously been appreciated.  These include:
  • Arsenic alters wound repair, both in vitro and in vivo
  • Altered calcium signaling, especially through purinergic receptors
  • Altered epithelial junctional proteins and function

Future Activities:

We are continuing to analyze data and finish manuscripts that will soon be submitted for review.  At least four additional manuscripts will be submitted in the next several months.  These include:

·         Elevated MMP-9 levels in human populations exposed to arsenic
·         Alterations in calcium signaling after exposure to arsenic
·         Altered expression of junctional proteins after arsenic exposure, in vitro and in vivo
·         Decreased airway epithelial repair in mice following chronic arsenic exposure


Journal Articles on this Report : 5 Displayed | Download in RIS Format

Publications Views
Other project views: All 18 publications 7 publications in selected types All 7 journal articles
Publications
Type Citation Project Document Sources
Journal Article Burgess JL, Meza MM, Josyula AB, Poplin GS, Kopplin MJ, McClellen HE, Sturup S, Lantz RC. Environmental arsenic exposure and urinary 8-OHdG in Arizona and Sonora. Clinical Toxicology 2007;45(5):490-498. R832095 (2005)
R832095 (2007)
  • Abstract from PubMed
  • Abstract: JCT-abstract
    Exit
  • Journal Article Josyula AB, Poplin GS, Kurzius-Spencer M, McClellen HE, Kopplin MJ, Sturup S, Lantz RC, Burgess JL. Environmental arsenic exposure and sputum metalloproteinase concentrations. Environmental Research 2006;102(3):283-290. R832095 (2005)
    R832095 (2006)
    R832095 (2007)
  • Abstract from PubMed
  • Full-text: ScienceDirect-Full Text PDF
    Exit
  • Abstract: ScienceDirect-Abstract & Full Text HTML
    Exit
  • Journal Article Lantz RC, Hays AM. Role of oxidative stress in arsenic-induced toxicity. Drug Metabolism Reviews 2006;38(4):791-804. R832095 (2005)
    R832095 (2006)
    R832095 (2007)
  • Abstract from PubMed
  • Abstract: Taylor&Francis-Abstract
    Exit
  • Journal Article Lantz RC, Lynch BJ, Boitano S, Poplin GS, Littau S, Tsaprailis G, Burgess JL. Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic. Environmental Health Perspectives 2007;115(4):586-591. R832095 (2005)
    R832095 (2006)
    R832095 (2007)
  • Full-text from PubMed
  • Abstract from PubMed
  • Associated PubMed link
  • Journal Article Olsen CE, Liguori AE, Zong Y, Lantz RC, Burges JL, Boitano S. Arsenic upregulates MMP-9 and inhibits wound repair in human airway epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology 2008;295(2):L293-302. R832095 (2005)
    R832095 (2007)
  • Full-text from PubMed
  • Abstract from PubMed
  • Associated PubMed link
  • Full-text: APS-Full Text PDF
    Exit
  • Abstract: APS-Abstract
    Exit
  • Supplemental Keywords:

    heavy metals, human health, animal, cellular, biomarkers, induced sputum, bronchial epithelial cells , Health, PHYSICAL ASPECTS, RFA, Scientific Discipline, Water, Arsenic, Biochemistry, Environmental Chemistry, Hazardous Waste, Health Risk Assessment, Physical Processes, Risk Assessments, arsenic exposure, bioaccumulation, biogeochemistry, biomarker measurements, contaminant transport, contaminated sediments, exposure, Health, RFA, Scientific Discipline, Water, POLLUTANTS/TOXICS, Health Risk Assessment, Risk Assessments, Environmental Chemistry, Hazardous Waste, Arsenic, Biochemistry, Water Pollutants, contaminant transport, contaminated sediments, biogeochemistry, bioaccumulation, biomarker measurements, risk management

    Progress and Final Reports:

    Original Abstract
  • 2006 Progress Report
  • 2007 Progress Report
  • 2008
  • Final
  • Top of Page

    The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.

    Project Research Results

    • Final
    • 2008
    • 2007 Progress Report
    • 2006 Progress Report
    • Original Abstract
    18 publications for this project
    7 journal articles for this project

    Site Navigation

    • Grantee Research Project Results Home
    • Grantee Research Project Results Basic Search
    • Grantee Research Project Results Advanced Search
    • Grantee Research Project Results Fielded Search
    • Publication search
    • EPA Regional Search

    Related Information

    • Search Help
    • About our data collection
    • Research Grants
    • P3: Student Design Competition
    • Research Fellowships
    • Small Business Innovation Research (SBIR)
    Contact Us to ask a question, provide feedback, or report a problem.
    Last updated April 28, 2023
    United States Environmental Protection Agency

    Discover.

    • Accessibility
    • Budget & Performance
    • Contracting
    • EPA www Web Snapshot
    • Grants
    • No FEAR Act Data
    • Plain Writing
    • Privacy
    • Privacy and Security Notice

    Connect.

    • Data.gov
    • Inspector General
    • Jobs
    • Newsroom
    • Open Government
    • Regulations.gov
    • Subscribe
    • USA.gov
    • White House

    Ask.

    • Contact EPA
    • EPA Disclaimers
    • Hotlines
    • FOIA Requests
    • Frequent Questions

    Follow.